PRMT1 and metabolic dysfunction-associated steatotic liver disease: This metabolic reprogramming, coupled with enhanced gluconeogenesis, suggests that PRMT1 coordinately drives NAFLD progression by dysregulating both hepatic glucose and lipid metabolism [130].